Literature DB >> 14634281

Cytokines as suppressors of apoptosis.

J Lotem1, L Sachs.   

Abstract

Many cytokines have been isolated by their ability to induce growth and have been called growth factors. But these cytokines are also essential to induce cell viability, and cell viability and growth can be separately regulated. Using as examples myeloid hematopoietic cells, lymphocytes and neuronal cells, in vitro and in vivo studies have shown the role of cytokines in inducing viability of different cell types during development to mature cells. Some cytokines can act on more than one cell type. Cytokines induce viability of normal and cancer cells by suppressing the apoptotic machinery activated by wild-type p53, or by cytotoxic agents including irradiation and compounds used in cancer chemotherapy. Cytokines can be used to decrease apoptosis in normal cells and inhibition of cytokine activity may improve cancer therapy by enhancing apoptosis in cancer cells. The apoptosis suppressing function of cytokines is mediated by changing the balance in the activity of apoptosis inducing and suppressing genes. Apoptosis suppression is upstream of caspase activation in the apoptotic process. Cytokines can suppress multiple pathways leading to apoptosis, only some of which were suppressed by other agents such as some antioxidants, Ca(2+)-mobilizing compounds and protease inhibitors.

Entities:  

Year:  1999        PMID: 14634281     DOI: 10.1023/a:1009614723237

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  12 in total

1.  Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin.

Authors:  J Lotem; R Kama; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 2.  Cellular senescence: from growth arrest to immunogenic conversion.

Authors:  D G A Burton; R G A Faragher
Journal:  Age (Dordr)       Date:  2015-03-20

3.  Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin.

Authors:  Peter Tsvetkov; Gad Asher; Veronica Reiss; Yosef Shaul; Leo Sachs; Joseph Lotem
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

4.  Induction in myeloid leukemic cells of genes that are expressed in different normal tissues.

Authors:  Joseph Lotem; Hila Benjamin; Dvir Netanely; Eytan Domany; Leo Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

5.  Lysosomal destabilization in p53-induced apoptosis.

Authors:  Xi-Ming Yuan; Wei Li; Helge Dalen; Joseph Lotem; Rachel Kama; Leo Sachs; Ulf T Brunk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 6.  Thalidomide in cancer treatment: a potential role in the elderly?

Authors:  Shufeng Zhou; Philip Kestell; Malcolm D Tingle; James W Paxton
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

7.  NQO1 stabilizes p53 through a distinct pathway.

Authors:  Gad Asher; Joseph Lotem; Rachel Kama; Leo Sachs; Yosef Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

8.  Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes.

Authors:  Joseph Lotem; Hilah Gal; Rachel Kama; Ninette Amariglio; Gideon Rechavi; Eytan Domany; Leo Sachs; David Givol
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-12       Impact factor: 11.205

9.  Functional genomics of hTERT gene in leukemic myelopoiesis.

Authors:  Deepak Kaul; A Gautam; S Varma; A Ahlawat
Journal:  Mol Cell Biochem       Date:  2008-04-13       Impact factor: 3.396

10.  Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis.

Authors:  Anna Wojtuszkiewicz; Gerrit J Schuurhuis; Floortje L Kessler; Sander R Piersma; Jaco C Knol; Thang V Pham; Gerrit Jansen; René J P Musters; Johan van Meerloo; Yehuda G Assaraf; Gertjan J L Kaspers; Sonja Zweegman; Jacqueline Cloos; Connie R Jimenez
Journal:  Mol Cell Proteomics       Date:  2016-01-22       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.